PDT Partners, LLC - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 160 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 1.73 and the average weighting 0.4%.

Quarter-by-quarter ownership
PDT Partners, LLC ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,172,375
-64.0%
37,077
+52.6%
0.15%
-36.8%
Q3 2021$3,260,000
-60.7%
24,300
-52.5%
0.23%
-57.3%
Q2 2021$8,290,000
+91.5%
51,200
-5.1%
0.55%
+76.2%
Q1 2021$4,329,000
-12.0%
53,937
-40.3%
0.31%
-6.3%
Q4 2020$4,918,000
+196.3%
90,400
+8.3%
0.33%
+201.8%
Q3 2020$1,660,000
-22.7%
83,509
-18.2%
0.11%
-24.7%
Q2 2020$2,147,000
+70.3%
102,143
-0.9%
0.15%
+46.0%
Q1 2020$1,261,000
+0.5%
103,100
+20.6%
0.10%
+29.9%
Q4 2019$1,255,000
+61.5%
85,517
+46.9%
0.08%
+67.4%
Q3 2019$777,000
-18.6%
58,200
-0.2%
0.05%
-17.9%
Q2 2019$954,000
-20.4%
58,288
-33.6%
0.06%
-16.4%
Q4 2018$1,198,000
-52.3%
87,743
+0.0%
0.07%
-35.6%
Q3 2018$2,511,000
-13.8%
87,726
-17.6%
0.10%
-6.3%
Q2 2018$2,914,000
+19.9%
106,509
-7.6%
0.11%
+35.4%
Q1 2018$2,431,000115,2540.08%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Discovery Value Fund 572,950$19,990,2265.79%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,145,091$39,952,2255.34%
MPM BioImpact LLC 455,238$15,883,2544.12%
ARK Investment Management 9,420,782$328,691,0842.85%
Atlas Venture Associates IX, LLC 10,000$348,9001.74%
Ghisallo Capital Management LLC 250,000$8,722,5001.55%
Nikko Asset Management Americas, Inc. 2,976,002$103,743,4301.49%
Prosight Management, LP 72,116$2,516,1271.37%
Rokos Capital Management LLP 826,063$28,391,7851.24%
Elmwood Wealth Management, Inc. 67,899$2,368,9961.18%
View complete list of INTELLIA THERAPEUTICS INC shareholders